Clinical Trial Update: Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating uptake and biodistribution of 89Zirconium-labeled ipilimumab in patients with metastatic melanoma who have previously b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Melanoma | Phase 2 | Status: UNKNOWN